NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.

YHGJ

Yunhong Green CTI Ltd.

There isn't enough reported data to score YHGJ yet.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

YHGJ Fundamentals

MetricStatus
Stable
Weak
Healthy
Weak

YHGJ's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are weak.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

YHGJ PE Valuation

YHGJ has no meaningful PE right now: it lost money over the past year.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

Analysts expect NIO's losses to shrink, with revenue growing.

YHGJ Forward outlook

There aren't enough analyst estimates for YHGJ to show an outlook.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

There is not enough scenario data to compare NIO and YHGJ's risk to reward.

YHGJ Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $3.35 on Nov 12.

There is not enough scenario data to compare NIO and YHGJ's risk to reward.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO has the stronger earnings trend. Trailing diluted EPS is down 117% for NIO versus YHGJ down 259%.

YHGJ Earnings Per Share

Q4 2023: $-0.10Q1 2024: $-0.60Q2 2024: $-0.70Q3 2024: $-0.70Q4 2024: $-0.70Q1 2025: $-0.60Q2 2026: $-1.11
Q4 2023: $-0.10Q1 2024: $-0.60Q2 2024: $-0.70Q3 2024: $-0.70Q4 2024: $-0.70Q1 2025: $-0.60Q2 2026: $-1.11
QuarterTTM EPSYoY
Q1 2025-$0.60$0.00
Q4 2024-$0.70-$0.60
Q4 2020-$18.60+$3.90
Q3 2020-$20.90+$1.90

YHGJ is still losing money, but far less than before: $1.11 per share over the past year, against $23.90 at its worst in mid-2020.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO has the edge over YHGJ on sales, with more consistent year-over-year improvement.

YHGJ Quarterly Revenue

Q3 2023: $2MQ4 2023: $7MQ1 2024: $5MQ2 2024: $4MQ3 2024: $3MQ4 2024: $6MQ1 2025: $5MQ2 2025: $5MQ3 2025: $3MQ4 2025: $6MQ1 2026: $6MQ2 2026: $4M
Q3 2023: $2MQ4 2023: $7MQ1 2024: $5MQ2 2024: $4MQ3 2024: $3MQ4 2024: $6MQ1 2025: $5MQ2 2025: $5MQ3 2025: $3MQ4 2025: $6MQ1 2026: $6MQ2 2026: $4M
QuarterRevenueYoY
Q2 2026$3.9M-29%
Q1 2026$6.2M+28%
Q4 2025$6.5M+5.3%
Q3 2025$3M+16%
Q2 2025$5.5M+25%
Q1 2025$4.8M-1.9%
Q4 2024$6.2M-8.9%
Q3 2024$2.5M+32%

YHGJ's revenue fell from its 2019 peak and has held roughly level since: $4M last quarter, down 29% from the same quarter a year ago.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: โˆ’$2.2BQ3 2024: $0Q4 2024: โˆ’$391MQ1 2025: $0Q2 2025: โˆ’$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: โˆ’$2.2BQ3 2024: $0Q4 2024: โˆ’$391MQ1 2025: $0Q2 2025: โˆ’$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO has the edge over YHGJ on cash flow, with more consistent year-over-year improvement.

YHGJ Free Cash Flow

Q3 2023: $877,000Q4 2023: โˆ’$760,000Q1 2024: โˆ’$921,000Q2 2024: $755,000Q3 2024: $726,000Q4 2024: โˆ’$2MQ1 2025: $950,000Q2 2025: $722,000Q3 2025: $560,000Q4 2025: โˆ’$2MQ1 2026: $209,000Q2 2026: $2M
Q3 2023: $877,000Q4 2023: โˆ’$760,000Q1 2024: โˆ’$921,000Q2 2024: $755,000Q3 2024: $726,000Q4 2024: โˆ’$2MQ1 2025: $950,000Q2 2025: $722,000Q3 2025: $560,000Q4 2025: โˆ’$2MQ1 2026: $209,000Q2 2026: $2M
QuarterFree cash flowYoY
Q2 2026$2.3M+218%
Q1 2026$209K-78%
Q4 2025-$2.5M-$307K
Q3 2025$560K-23%
Q2 2025$722K-4.4%
Q1 2025$950K+$1.9M
Q4 2024-$2.2M-$1.4M
Q3 2024$726K-17%

YHGJ still generates free cash flow, though less than at its 2026 peak: $593,000 over the past year.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

YHGJ Total Shares

Q3 2023: 2MQ4 2023: 2MQ1 2024: 2MQ2 2024: 2MQ3 2024: 3MQ4 2024: 2MQ1 2025: 3MQ2 2025: 3MQ3 2025: 3MQ4 2025: 3MQ1 2026: 3MQ2 2026: 3M
Q3 2023: 2MQ4 2023: 2MQ1 2024: 2MQ2 2024: 2MQ3 2024: 3MQ4 2024: 2MQ1 2025: 3MQ2 2025: 3MQ3 2025: 3MQ4 2025: 3MQ1 2026: 3MQ2 2026: 3M
PeriodChange %Net change
Quarterly+0.3%+8.1K shares
1 year0%+556 shares
3 years+30%+605K shares
5 years+432%+2.1M shares
Available history+580%+2.2M shares

YHGJ has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

YHGJ Net Leverage

Q1 2025: 678.6xQ2 2025: 15.8xQ3 2025: 11.3x
Q1 2025: 678.6xQ2 2025: 15.8xQ3 2025: 11.3x
QuarterNet LeverageStatus
Q3 202511.3xHigh
Q2 202515.8xHigh
Q1 2025678.6xHigh

YHGJ's net debt is about 11 years of its operating earnings (EBITDA).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

YHGJ Weekly Momentum

MetricValueStatus
RSI54.3Neutral
Stochastic68.0Neutral

YHGJ's weekly RSI is 54 (neutral) and its Stochastic is 68 (neutral).

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

YHGJ PE vs Consumer Cyclical Sector

YHGJ has no meaningful PE right now: it lost money over the past year.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

YHGJ Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.9115% above
20 week MA$2.9414% above
50 week MA$3.214.4% above
100 week MA$5.1435% below
200 week MA$10.568% below

YHGJ has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to โˆ’64% in 2022. It's down 40% so far in 2026.

YHGJ Yearly ROI

YearStart priceEnd priceROI
2020$7.40$19.1+158%
2021$19.1$12.6-34%
2022$12.6$10.5-17%
2023$10.5$21.4+104%
2024$21.4$5.10-76%
2025$5.10$3.78-26%
2026 YTD$3.78$3.35-11%

YHGJ has the edge over NIO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key